HuGE Literature Finder
Records 1-13
|
The Association of Fractalkine Receptor (T280M) Polymorphism in the Pathogenesis of Acute Coronary Syndrome in the Egyptian Population.
Current pharmaceutical biotechnology 2018 19 (11): 869-876. Hassan Dina S, Hashad Ingy M, Abdel Rahman Mohamed F, Abdel-Maksoud Sahar |
|
Chemokine CX3CL1 and its receptor CX3CR1 are associated with human atherosclerotic lesion volnerability.
Thrombosis research 2015 Jun 135 (6): 1147-53. Zhang Xiaolin, Feng Xueyao, Cai Wenzhi, Liu Tengfei, Liang Zhenyang, Sun Ying, Yan Chenghui, Han Yali |
|
Two polymorphisms in the Fractalkine receptor CX3CR1 gene influence the development of atherosclerosis: a meta-analysis.
Disease markers 2014 2014 913678. Wu Jian, Yin Rui-Xing, Lin Quan-Zhen, Guo Tao, Shi Guang-Yuan, Sun Jia-Qi, Shen Shao-Wen, Li Qi |
|
Association of V249I and T280M polymorphisms in the chemokine receptor CX3CR1 gene with early onset of coronary artery disease among North Indians.
Genetic testing and molecular biomarkers 2012 Jul 16 (7): 756-60. Singh Neha, Rai Himanshu, Sinha Nakul, Kumar Sudeep, Pandey Chandra M, Agrawal Suraks |
|
Association of common polymorphisms in the fractalkine receptor (CX3CR1) with obesity.
Obesity (Silver Spring, Md.) 2011 Jan 19 (1): 222-7. Sirois-Gagnon Dave, Chamberland Annie, Perron Stéphanie, Brisson Diane, Gaudet Daniel, Laprise Catheri |
|
Genetic diversity of CX3CR1 gene and coronary artery disease: new insights through a meta-analysis.
Atherosclerosis 2009 Nov 207 (1): 8-15. Apostolakis Stavros, Amanatidou Virginia, Papadakis Emmanouil G, Spandidos Demetrios |
|
Association of polymorphisms in the chemokine receptor CX3CR1 gene with coronary artery disease.
Cytokine 2009 Sep 47 (3): 224-7. Matzhold Eva M, Trummer Olivia, Grünbacher Gerda, Zulus Barbara, Boehm Bernhard O, März Winfried, Renner Wilfri |
|
Search for an association between V249I and T280M CX3CR1 genetic polymorphisms, endothelial injury and preeclampsia: the ECLAXIR study.
PloS one 2009 4 (7): 7. Stepanian A, Benchenni S, Beillat-Lucas T, Omnes S, Defay F, Peynaud-Debayle E, Baron G, Le Querrec A, Dreyfus M, Salomon L, Tsatsaris V, de Prost D, Mandelbrot L |
|
Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early-onset coronary artery disease in patients with no classic risk factors.
Scandinavian journal of clinical and laboratory investigation 2008 68 (4): 286-91. Nassar B A, Nanji A A, Ransom T P, Rockwood K, Kirkland S A, Macpherson K, Connelly P W, Johnstone D E, O'Neill B J, Bata I R, Andreou P, Title L |
|
Effects of polymorphisms in chemokine ligands and receptors on susceptibility to coronary artery disease.
Thrombosis research 2007 119 (1): 63-71. Apostolakis Stavros, Baritaki Stavroula, Kochiadakis Georgios E, Igoumenidis Nikolaos E, Panutsopulos Dimitrios, Spandidos Demetrios |
|
Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndrome. A possible implication of fractalkine in inflammatory activation.
Thrombosis and haemostasis 2005 May 93 (5): 949-54. Niessner Alexander, Marculescu Rodrig, Haschemi Arvand, Endler Georg, Zorn Gerlinde, Weyand Cornelia M, Maurer Gerald, Mannhalter Christine, Wojta Johann, Wagner Oswald, Huber Ku |
|
Association between polymorphism in the chemokine receptor CX3CR1 and coronary vascular endothelial dysfunction and atherosclerosis.
Circulation research 2001 Aug 89 (5): 401-7. McDermott D H, Halcox J P, Schenke W H, Waclawiw M A, Merrell M N, Epstein N, Quyyumi A A, Murphy P |
|
Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease.
Blood 2001 Apr 97 (7): 1925-8. Moatti D, Faure S, Fumeron F, Amara Mel-W, Seknadji P, McDermott DH, Debré P, Aumont MC, Murphy PM, de Prost D, Combadière C |
- Page last reviewed:Oct 1, 2020
- Page last updated:Jan 28, 2021
- Content source: